Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thanaporn Bussabawalai"'
Autor:
Oktavia Lilyasari, Yusuf Subekti, Nur Atika, Lucia Kris Dinarti, Septiara Putri, Cicih Opitasari, Anggita Bunga Anggraini, Thanaporn Bussabawalai, Yot Teerawattananon
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost. Methods Based on a societal pers
Externí odkaz:
https://doaj.org/article/d4a594443a1140739a563736fd9ada39
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 17, Iss 1, Pp 1-12 (2019)
Abstract Background Many patients develop tumour recurrence within a few years after undergoing surgical resection of gastrointestinal stromal tumours (GIST). Adjuvant imatinib treatment is recommended for patients with high risk of GIST recurrence a
Externí odkaz:
https://doaj.org/article/ac9f50cb49da4e76af31a45883ddc745
Autor:
Roongnapa Khampang, Thanaporn Bussabawalai, Maneechotirat Santi, Danai Chinnacom, Suppawat Permpolsuk, Pigunkaew Sinam, Rapeepong Suphanchaimat
Publikováno v:
Outbreak, Surveillance, Investigation & Response (OSIR) Journal. 13:160-167
Despite remarkable efforts from the Ministry of Public Health (MOPH) to promote access to health services among migrants, there remains an important gap about equity in utilizing health services among migrants residing in different economic status ar
Autor:
Nur Atika, Cicih Opitasari, Thanaporn Bussabawalai, Septiara Putri, Yot Teerawattananon, Oktavia Lilyasari, Lucia Kris Dinarti, Anggita Bunga Anggraini, Yusuf Subekti
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Health Services Research, Vol 19, Iss 1, Pp 1-9 (2019)
Background This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost. Methods Based on a societal perspective,
Autor:
Oktavia Lilyasari, Subekti, Yusuf, Atika, Nur, Dinarti, Lucia, Septiara Putri, Cicih Opitasari, Anggita Anggraini, Thanaporn Bussabawalai, Yot Teerawattananon
Data collection form for direct medical cost, Data collection form for collecting direct medical cost from hospital billing data. (DOC 119 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5081787518dd2c6005aa1fdcae45dd36
Publikováno v:
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation, Vol 17, Iss 1, Pp 1-12 (2019)
Cost Effectiveness and Resource Allocation, Vol 17, Iss 1, Pp 1-12 (2019)
© 2019 The Author(s). Background: Many patients develop tumour recurrence within a few years after undergoing surgical resection of gastrointestinal stromal tumours (GIST). Adjuvant imatinib treatment is recommended for patients with high risk of GI
Autor:
Pattara Leelahavarong, Usa Chaikledkaew, Thanaporn Bussabawalai, Yot Teerawattananon, Watsamon Thongsri, Kritvikrom Durongpisitkul, Suthep Wanitkun
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 16:525-536
This study aims to compare the lifetime costs and health outcomes of both first-line and sequential combination treatments with standard treatment for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) (PAH-CHD) pati